Related references
Note: Only part of the references are listed.Rebound disease in multiple sclerosis
Paul S. Giacomini
MULTIPLE SCLEROSIS JOURNAL (2018)
Rebound disease in multiple sclerosis
Paul S. Giacomini
MULTIPLE SCLEROSIS JOURNAL (2018)
Treatment of multiple sclerosis during pregnancy - safety considerations
Jan Thoene et al.
EXPERT OPINION ON DRUG SAFETY (2017)
Glatiramer acetate during early pregnancy: A prospective cohort study
Sandra Herbstritt et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Interferon-beta exposure during first trimester is safe in women with multiple sclerosisA prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry
Sandra Thiel et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Glatiramer acetate during early pregnancy: A prospective cohort study
Sandra Herbstritt et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Interferon-beta exposure during first trimester is safe in women with multiple sclerosisA prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry
Sandra Thiel et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis
Goeril Karlsson et al.
NEUROLOGY (2014)
Natalizumab Use During the Third trimester of Pregnancy
Aiden Haghikia et al.
JAMA NEUROLOGY (2014)
Postnatal Development in Cynomolgus Monkeys Following Prenatal Exposure to Natalizumab, an α4 Integrin Inhibitor
Nancy G. Wehner et al.
BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY (2009)
A comparison of observational studies and randomized, controlled trials.
K Benson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
